MDAnderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
MDAnderson Cancer Center has participated in 4 clinical trials.
Therapeutic areas: Melanoma, Metastatic Melanoma, Mucosal Melanoma.
Sponsors: Craig L Slingluff, Jr, Millendo Therapeutics, Inc., Wake Forest University Health Sciences.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
MDAnderson Cancer Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MDAnderson Cancer Center has 4 clinical trials on record. Their work covers Melanoma, Metastatic Melanoma, Mucosal Melanoma.
Yes — MDAnderson Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.